We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Diagnostic Support Tool Improves Melanoma Detection

By HospiMedica International staff writers
Posted on 28 Sep 2020
Print article
Image: The Nevisense EIS device (Photo courtesy of SciBase)
Image: The Nevisense EIS device (Photo courtesy of SciBase)
A new point-of-care (POC) device helps detect malignant melanoma by gathering and analyzing precise electrical measurements in the skin.

The SciBase (Sundbyberg, Sweden) Nevisense device uses electrical impedance spectroscopy (EIS) to extract multi-depth spectra that reflect changes in cellular structure, cellular orientation, and cell sizes. Non-invasive electrodes apply an discreet alternating potential between the bars on the tip of the probe; in order to completely cover the lesion, the measurements are performed in 10 permutations covering both shallow measurements between neighboring electrode bars, as well as deeper measurements between more distant electrode bars.

The EIS measurements at low frequencies are affected by the extracellular environment, whereas both the intra- and extracellular environments affect measurements at higher frequencies. Within seconds, an advanced algorithm classifies the lesion based on measurement data. The results are analyzed and displayed on the Nevisense screen as an EIS score output reflecting the degree of atypia identified. The result is combined with a visual inspection by a medical professional trained in the clinical diagnosis of skin cancer, and is intended for documentation and not for diagnostic purposes.

In studies to evaluate the differences between practicing dermatologists, physician's assistants, nurses and residents, all clinicians evaluated lesions using visual evaluation only, and then added the Nevisense information. In over 25,000 evaluations, the number of missed melanomas fell from 7% to less than one percent. Overall sensitivity increased on average by 14%, and specificity by 10.2%. In all, clinicians identified 1,343 more melanomas with Nevisense compared to visual evaluation alone.

“Clinicians face difficult decisions every day when they evaluate moles, so it was very positive to see that Nevisense could so significantly improve their accuracy. Nevisense was able to help clinicians of all levels of experience, and especially those who were most in need of support,” said Simon Grant, CEO of SciBase. “This is further proof of the potential for Nevisense to improve the standard of care of melanoma detection in the United States and will provide timely support to our ongoing reimbursement process.”

Melanoma, an aggressive form of skin cancer, is most often considered fatal once the cells (cutaneous, mucosal, or ocular) convert to metastatic melanoma (also known as stage IV melanoma) and spread through the lymph nodes to distant sites in the body and/or to the body's organs such as the liver, lungs, bones, and brain. Once it becomes metastatic it is usually not amenable to surgical treatment.

Related Links:
SciBase

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Heart-Lung Machine
HL 40

Print article

Channels

Critical Care

view channel
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation,... Read more

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.